Cancer Survivors' Fear of Cancer Recurrence
MHPII
Development and Evaluation of An Innovative Program in Mental Health Promotion
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
The purpose of this study is to develop and evaluate the tailored support for the fear of cancer recurrence in breast, head and neck, colon-rectal or prostate cancer survivors. Based on screening for fear of cancer recurrence, different levels of supportive care will be provided, starting with the oncology nurses' health education and information for those having a lower level of concern. Those who have medium or higher levels of concerns will be randomized to receive "stepping up" either a "ConquerFear psychological cognitive training" or a "healthy lifestyle - individualized exercise and nutrition guidance".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2028
April 21, 2026
April 1, 2026
2.1 years
April 14, 2026
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fear of Cance Recurrence
the change of FCR (Fear of Cancer Recurrence) score as measured by FCRI
From the baseline to the 3 months after intervention at 5 months
Secondary Outcomes (2)
Psychological distress
From the baseline to the 3 months after intervention at 5 months
QOL
From the baseline to the 3 months after intervention at 5 months
Other Outcomes (2)
Metacognition
From the baseline to the 3 month after intervention at 5 months
Intervention Satisfaction
at the end of intervention at 2 month
Study Arms (3)
education group
ACTIVE COMPARATORone session of nurses' education and information
ConquerFear group
EXPERIMENTALa 6-session add-on psychological cognitive training performed by a trained psychologist
Healthy lifestyle group
EXPERIMENTALa 6-session add-on individualized nutrition and exercise guidance performed by a trained nutritionist and an exercise expert.
Interventions
individualized nutrition and exercise guidance
Eligibility Criteria
You may qualify if:
- stage I, II, III breast, head and neck, colo-rectal, proste cancer and completion of primary cancer treatment
- report of fear of cancer recurrence
- able to read and listen in Manderin and without a cognitive defect
You may not qualify if:
- diagnosed with severe mental illness
- difficult to communicate in Manderin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Park SY, Lim JW. Cognitive behavioral therapy for reducing fear of cancer recurrence (FCR) among breast cancer survivors: a systematic review of the literature. BMC Cancer. 2022 Feb 28;22(1):217. doi: 10.1186/s12885-021-08909-y.
PMID: 35227244BACKGROUNDNg DWL, Ng R, Guo C, Chan J, Fielding R, Tang JWC, Li WWY, Foo CC, Kwong A, Ng SS, Suen D, Fung S, Chun OK, Chan KKL, Chang ATY, Butow P, Lam WWT. ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors. Psychother Psychosom. 2025 Aug 8:1-17. doi: 10.1159/000547888. Online ahead of print.
PMID: 40784346BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shiuyu C. Katie Lee, PhD
National Taipei University of Nursing and Health Science
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 21, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
May 31, 2028
Study Completion (Estimated)
November 30, 2028
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
It is restricted by the sponsors.